Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
Yaolu Wei, Yan Li, Yen‐An Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, et al.
Life Sciences (2024) Vol. 356, pp. 123033-123033
Closed Access | Times Cited: 13
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13179-13179
Open Access | Times Cited: 37
Identification of approved drugs with ALDH1A1 inhibitory potential aimed at enhancing chemotherapy sensitivity in cancer cells: an in-silico drug repurposing approach
Sanjay Kumar Paul, Abdelmadjid Guendouzi, Agniswar Banerjee, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-15
Closed Access | Times Cited: 7
Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction
Marwa M. Abu‐Serie, Satoru Osuka, Lamiaa A Heikal, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Aldehyde dehydrogenase 1 family: A potential molecule target for diseases
Xiangning Duan, Haoliang Hu, Lingzhi Wang, et al.
Cell Biology International (2024) Vol. 48, Iss. 7, pp. 909-922
Closed Access | Times Cited: 7
A comparative study of smart nanoformulations of diethyldithiocarbamate with Cu4O3 nanoparticles or zinc oxide nanoparticles for efficient eradication of metastatic breast cancer
Marwa M. Abu‐Serie, Eisayeda Zeinab A. Abdelfattah
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids
Marwa M. Abu‐Serie
Nanomedicine (2024) Vol. 19, Iss. 11, pp. 979-994
Closed Access | Times Cited: 6
Molecular Biomarkers and Signaling Pathways of Cancer Stem Cells in Colorectal Cancer
Mohamed M. Omran, Manar S. Fouda, Sara A. Mekkawy, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 6
MACC1 Regulates LGR5 to Promote Cancer Stem Cell Properties in Colorectal Cancer
Müge Erdem, Kyung Hwan Lee, Markus Hardt, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 604-604
Open Access | Times Cited: 5
Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer
Alexandru Filippi, Teodora Deculescu-Ioniță, Ariana Hudiță, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 631-631
Open Access
Biomarkers, isolation methods, and therapeutic implications of breast cancer stem cells
Peik Lin Teoh, Neha Saini
Cancer Pathogenesis and Therapy (2025)
Open Access
Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer
Yanfang Wang, Hui Liu, Xiang Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma
Dinh-Xuan Pham, Tien Hsu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway
Tanapon Soonthonsrima, Ismail Dwi Putra, Preeyaphan Phookphan, et al.
Chemical Research in Toxicology (2025)
Closed Access
Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access
FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system
Xiaolong Liu, Xueyan Zhang, T. X. Zeng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Disruption of the sorcin‒PAX5 protein‒protein interaction induces ferroptosis by promoting the FBXL12-mediated ubiquitination of ALDH1A1 in pancreatic cancer
Yahui Ding, Yongping Bai, Tianyang Chen, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells
Maria Ros, Gerard Riesco-Llach, Emma Polonio‐Alcalá, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7446-7446
Open Access | Times Cited: 4
Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer
Wen Liu, Miaomiao Wang, Miao Wang, et al.
Medicine (2023) Vol. 102, Iss. 32, pp. e34611-e34611
Open Access | Times Cited: 11
The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
Natalia Iżycka, Marcin Ruciński, Małgorzata Andrzejewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2400-2400
Open Access | Times Cited: 10
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling
Valerio Ciccone, Vittoria Simonis, Cinzia Del Gaudio, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116252-116252
Open Access | Times Cited: 3
Strategies for the Isolation and Identification of Gastric Cancer Stem Cells
Jianhua Wang, Jie Qu, Qiang Hou, et al.
Stem Cells International (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells
Salma A. Al-Shamma, Dana M. Zaher, Fatema Hersi, et al.
Life Sciences (2023) Vol. 320, pp. 121541-121541
Closed Access | Times Cited: 9
Cancer stem cell–immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet
Aishwarya Guha, Kuntal Kanti Goswami, Jasmine Sultana, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
The biological roles of CD47 in ovarian cancer progression
Linan Xing, Zhao Wang, Yue Feng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top